Literature DB >> 11825965

Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies.

P J Pussinen1, T Vilkuna-Rautiainen, G Alfthan, K Mattila, S Asikainen.   

Abstract

Periodontitis is a common chronic oral infection caused by gram-negative bacteria, including Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontitis evokes inflammatory host response locally in the periodontium but also systemically. The systemic humoral antibody response against oral pathogens can conveniently be measured by an immunoassay. The aim of the study was to measure serum immunoglobulin G class antibodies against A. actinomycetemcomitans and P. gingivalis by an enzyme-linked immunosorbent assay (ELISA) in which mixtures of several serotypes of the pathogens were used as antigens to avoid biasing of the results in favor of a particular strain. For A. actinomycetemcomitans the antigen consisted of six strains representing serotypes a, b, c, d, and e and one nonserotypeable strain. In the P. gingivalis ELISA, antigens representing serotypes a, b, and c were used. Serum samples from 90 subjects, including 35 samples from patients with diagnosed periodontitis, 10 samples from periodontally healthy controls, and 45 samples from randomly selected apparently healthy volunteers (referred to as "healthy subjects"), were tested. For both pathogens the antibody levels (means +/- standard deviations) of the patients--xpressed as area under the dilution curve--were significantly higher than those for healthy controls or healthy subjects, with values for A. actinomycetemcomitans and P. gingivalis, respectively, as follows: patients, 22.60 +/- 9.94 mm(2) and 26.72 +/- 11.13 mm(2); healthy controls, 9.99 +/- 3.92 mm(2) and 6.90 +/- 3.38 mm(2); and healthy subjects, 16.85 +/- 6.67 mm(2) and 8.51 +/- 4.23 mm(2). The serotype mixture ELISA is suitable for measuring antibodies against periodontal pathogens in large epidemiological studies in order to evaluate the role of periodontitis as a risk factor for other diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11825965      PMCID: PMC153358          DOI: 10.1128/JCM.40.2.512-518.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

Review 1.  Systemic humoral immune responses in periodontal disease.

Authors:  J L Ebersole
Journal:  Crit Rev Oral Biol Med       Date:  1990

2.  Identification and characterization of B-cell epitopes of a 53-kDa outer membrane protein from Porphyromonas gingivalis.

Authors:  K Oyaizu; H Ohyama; F Nishimura; H Kurihara; S Matsushita; H Maeda; S Kokeguchi; H Hongyo; S Takashiba; Y Murayama
Journal:  Oral Microbiol Immunol       Date:  2001-04

3.  Serum antibodies to Bacteroides gingivalis in periodontitis: a longitudinal study.

Authors:  C Mouton; M Desclauriers; H Allard; M Bouchard
Journal:  J Periodontal Res       Date:  1987-09       Impact factor: 4.419

4.  Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment.

Authors:  J Slots; J J Zambon; B G Rosling; H S Reynolds; L A Christersson; R J Genco
Journal:  J Periodontal Res       Date:  1982-09       Impact factor: 4.419

5.  An ELISA for measuring serum antibodies to Actinobacillus actinomycetemcomitans.

Authors:  J L Ebersole; D E Frey; M A Taubman; D J Smith
Journal:  J Periodontal Res       Date:  1980-11       Impact factor: 4.419

6.  The relationship of antibody response categories to clinical parameters of periodontal disease.

Authors:  J L Ebersole; M A Taubman; D J Smith; D E Frey; A D Haffajee; S S Socransky
Journal:  J Periodontal Res       Date:  1984-11       Impact factor: 4.419

7.  Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis.

Authors:  J V Califano; R E Schifferle; J C Gunsolley; A M Best; H A Schenkein; J G Tew
Journal:  J Periodontol       Date:  1999-07       Impact factor: 6.993

8.  Use of synthetic oligonucleotide DNA probes for the identification of Bacteroides gingivalis.

Authors:  B J Moncla; P Braham; K Dix; S Watanabe; D Schwartz
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

9.  Rapid quantitative microenzyme-linked immunosorbent assay for tetanus antibodies.

Authors:  A K Sedgwick; M Ballow; K Sparks; R C Tilton
Journal:  J Clin Microbiol       Date:  1983-07       Impact factor: 5.948

10.  Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease.

Authors:  J J Zambon; J Slots; R J Genco
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

View more
  20 in total

1.  Antigenically diverse reference strains and autologous strains of Actinobacillus actinomycetemcomitans are equally efficient antigens in enzyme-linked immunosorbent assay analysis.

Authors:  Tiina Vilkuna-Rautiainen; Pirkko J Pussinen; Kimmo Mattila; Marja Vesanen; Heidi Ahman; Başak Doğan; Sirkka Asikainen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Actinobacillus actinomycetemcomitans serotype d-specific antigen contains the O antigen of lipopolysaccharide.

Authors:  Laura Lakio; Susanna Paju; Georg Alfthan; Terttu Tiirola; Sirkka Asikainen; Pirkko J Pussinen
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  C-reactive protein as a systemic marker of inflammation in periodontitis.

Authors:  A Pejcic; L J Kesic; J Milasin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-06       Impact factor: 3.267

4.  Association of rheumatoid arthritis disease activity and antibodies to periodontal bacteria with serum lipoprotein profile in drug naive patients.

Authors:  Aulikki Kononoff; Pia Elfving; Pirkko Pussinen; Sohvi Hörkkö; Hannu Kautiainen; Leena Arstila; Leena Laasonen; Elina Savolainen; Helena Niinisalo; Jarno Rutanen; Olga Marjoniemi; Mari Hämäläinen; Katriina Vuolteenaho; Eeva Moilanen; Oili Kaipiainen-Seppänen
Journal:  Ann Med       Date:  2020-02-10       Impact factor: 4.709

5.  Characterization of a natural mouse monoclonal antibody recognizing epitopes shared by oxidized low-density lipoprotein and chaperonin 60 of Aggregatibacter actinomycetemcomitans.

Authors:  Chunguang Wang; Jari Kankaanpää; Outi Kummu; S Pauliina Turunen; Ramin Akhi; Ulrich Bergmann; Pirkko Pussinen; Anne M Remes; Sohvi Hörkkö
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

6.  Association of serum immunoglobulin G (IgG) levels against two periodontal pathogens and prothrombotic state: a clinical pilot study.

Authors:  Sergio Bizzarro; Elena A Nicu; Ubele van der Velden; Marja L Laine; Bruno G Loos
Journal:  Thromb J       Date:  2010-11-04

7.  TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjects.

Authors:  Angela R Kamer; Ronald G Craig; Elizabeth Pirraglia; Ananda P Dasanayake; Robert G Norman; Robert J Boylan; Andrea Nehorayoff; Lidia Glodzik; Miroslaw Brys; Mony J de Leon
Journal:  J Neuroimmunol       Date:  2009-09-19       Impact factor: 3.478

8.  Chlamydial and periodontal pathogens induce hepatic inflammation and fatty acid imbalance in apolipoprotein E-deficient mice.

Authors:  Kati Hyvärinen; Anita M Tuomainen; Saara Laitinen; Igor L Bykov; Liisa Törmäkangas; Kai Lindros; Reijo Käkelä; Georg Alfthan; Irma Salminen; Matti Jauhiainen; Petri T Kovanen; Maija Leinonen; Pekka Saikku; Pirkko J Pussinen
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

9.  Periodontitis is associated with a low concentration of vitamin C in plasma.

Authors:  Pirkko J Pussinen; Tiina Laatikainen; Georg Alfthan; Sirkka Asikainen; Pekka Jousilahti
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease.

Authors:  K Yamazaki; T Honda; H Domon; T Okui; K Kajita; R Amanuma; C Kudoh; S Takashiba; S Kokeguchi; F Nishimura; M Kodama; Y Aizawa; H Oda
Journal:  Clin Exp Immunol       Date:  2007-07-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.